Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C

Background Chronic hepatitis C is associated with significant morbidity and mortality as a consequence of progression to cirrhosis, hepatocellular carcinoma, and liver failure. Current treatment for chronic hepatitis C with pegylated interferon (IFN) and ribavirin is associated with suboptimal respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, K Rajender, Belle, Steven H, Fried, Michael W, Afdhal, Nezam, Navarro, Victor J, Hawke, Roy L, Wahed, Abdus S, Doo, Edward, Meyers, Catherine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2012
Materias:
Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293174/
https://www.ncbi.nlm.nih.gov/pubmed/22058086
http://dx.doi.org/10.1177/1740774511427064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293174/
https://www.ncbi.nlm.nih.gov/pubmed/22058086
http://dx.doi.org/10.1177/1740774511427064

Ejemplares similares